American Diabetes Association Scientific Sessions

Healio brings you the highlights from the American Diabetes Association Scientific Sessions. Refer back to this page often for the latest news from ADA, perspectives and interviews with leading researchers and clinicians, and to review archives of past meetings.

Meeting NewsPerspective

Head-to-head comparison shows real-world accuracy differences among CGM devices

June 23, 2018
ORLANDO, Fla. — Among adults with type 1 diabetes concurrently wearing three continuous glucose monitoring devices, accuracy of the devices was…
Meeting News

For teens with type 1 diabetes, apps offer connectivity, but with limits

June 22, 2018
ORLANDO, Fla. — Apps for smartphones and tablets offer a personalized way for teens with type 1 diabetes to manage their disease, but it is…
Meeting News

New focus on member input at ADA annual meeting

June 21, 2018
Attendees at this year’s American Diabetes Association’s 78th Scientific Sessions can expect a new focus on member’s suggestions…
Meeting News

DEVOTE: Insulin degludec demonstrates CV safety, reduced risk for severe hypoglycemia

June 21, 2017
SAN DIEGO — In the DEVOTE cardiovascular outcomes trial, insulin degludec was noninferior to insulin glargine for the primary endpoint of major…
Meeting News

Top takeaways from American Diabetes Association Scientific Sessions

June 16, 2017
The American Diabetes Association 77th Scientific Sessions recently wrapped in San Diego. Topics discussed included lowering cardiovascular risks in…
Meeting News

Hybrid closed-loop system viable for children with type 1 diabetes

June 15, 2017
SAN DIEGO — A hybrid-closed loop insulin control system used in children with type 1 diabetes was safe for both overall and overnight control…
Meeting News

SMBG fails to improve glycemic control in adults with type 2 diabetes

June 15, 2017
SAN DIEGO — Self-monitoring of blood glucose with or without tailored messages did not significantly improve glycemic control compared with no…
Meeting News

Oral, subcutaneous insulin similar in efficacy

June 15, 2017
SAN DIEGO — Adults with type 2 diabetes assigned to once-daily oral insulin achieve similar HbA1c and fasting plasma glucose levels compared…
Meeting NewsPerspective

Long-term metformin therapy reduces CVD risk in type 1 diabetes

June 15, 2017
SAN DIEGO — Middle-aged adults with long-standing type 1 diabetes at high risk for cardiovascular disease who added metformin to insulin…
Meeting News

Oral insulin therapy fails to prevent type 1 diabetes, but some see disease delay

June 15, 2017
SAN DIEGO — In adults with two or more antibodies predicting the development of type 1 diabetes, treatment with daily oral insulin therapy did…